A Phase 1 Safety Study of SANGUINATE™ In Patients With Acute Severe Anemia.
Clinical trial NCT02754999 · COMPLETED
Trial details
- NCT number
- NCT02754999
- Sponsor
- Prolong Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-05-17
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.